Skip to content
Peptigraph home

Does retatrutide cause muscle loss?

Some lean mass is lost along with fat, but in the one body-composition analysis the share of weight lost as lean mass was similar to other obesity treatments.

GLP-1 / GIP / glucagon triple agonistUpdated

Short answer

Some lean mass is lost along with fat, but in the one body-composition analysis the share of weight lost as lean mass was similar to other obesity treatments.[1]

The authors wrote that the result could reassure that retatrutide does not take a greater proportion of lean mass despite producing larger overall weight loss.[1]

What limits that answer

The data come from a diabetes-only substudy of an earlier trial, and only 103 participants had both a baseline and a week 36 body scan.[1]

The company that makes the drug paid for that substudy.[1]

A review of incretin-type weight-loss drugs, retatrutide among them, says the class causes rapid lean-mass loss of roughly 10% or 6 kg; this is a class-level figure, not a retatrutide measurement.[2]

A dermatology review cites early trial data as showing a body-composition profile that favours fat over lean mass loss.[3]

More on Retatrutide

Sources

  1. 1Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial.The lancet. Diabetes & endocrinology · 2025PMID 40609566Accessed 2 Oct 2026
  2. 2Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?Diabetes care · 2024PMID 38687506Accessed 2 Oct 2026
  3. 3Integrating glucagon-like peptide-1 receptor agonists into dermatology practice: Safety and monitoring strategies.Clinics in dermatology · 2026PMID 42562129Accessed 29 Oct 2026

Found an error? Report a correction.